Navigation Links
Sunshine Heart Provides C-Pulse U.S. Clinical Update
Date:7/28/2009

as less than ordinary cause fatigue, palpitation, and/or shortness of breath. The most common treatments for Class III heart failure are drugs, lifestyle adjustments, family education, device therapy (i.e. heart failure pacemaker with or without a defibrillator), or surgery. A major medical treatment challenge is that the drug therapy and CRT options often stop alleviating symptoms over time, hence the need for C-Pulse heart assist.

About Sunshine Heart

Sunshine Heart (ASX: SHC) (www.sunshineheart.com) is a global medical device company, committed to the commercialization of C-Pulse(TM) an implantable, non-blood contacting, heart assist therapy for the treatment of people with advanced heart failure. C-Pulse reduces the symptoms of heart failure through the use of counterpulsation technology which enables an increase in cardiac output, an increase in coronary blood flow and reduction in the heart's pumping load. The Company has received approval from the US Food and Drug Administration (FDA) to conduct a 20 person U.S. clinical trial with C-Pulse and patient enrollment has commenced. Sunshine Heart listed on the ASX in September 2004 has a presence in Australia, New Zealand and the United States of America.

For further information, please visit www.sunshineheart.com or contact:

    Contact:                             Investors/Media:
    Don Rohrbaugh                        The Ruth Group
    Chief Executive Officer              R.J. Pellegrino/Scott Lerman
    +1 714 259 0732                      646-536-7009/7013
    don.rohrbaugh@sunshineheart.com      rpellegrino@theruthgroup.com
                                         '/>"/>
SOURCE  Sunshine Heart
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 

Related medicine news :

1. Escape the Cold and Flu Season With a Free Vacation to the Sunshine State
2. Join the Vitamin D Revolution: How to Get 30 Minutes of Daily Sunshine for Optimal Health
3. Florida Orange Juice Adds a Healthy Splash of Flavor and Sunshine to Recipes
4. Run Your Buns off in the 26th Annual Schlotzskys(R) Bun Run(R) Benefitting Austin Sunshine Camps
5. Flower power may bring ray of sunshine to cancer sufferers
6. Let the sunshine in to protect your heart this winter
7. Sunshine vitamin link to cognitive problems in older people
8. Test Your Vitamin D Knowledge: Wellesse Liquid Sunshine Instant Win and Sweepstakes
9. Time for Change - Sunshine and Exercise Part of Holistic Treatment for Osteoporosis
10. Prescribing sunshine for multiple sclerosis?
11. Camp Sunshine Celebrates 25th Anniversary
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... of hearing aids has been brought into reach for many Houstonians ... based hearing plan. , ... (PRWEB) December 16, 2009 ... for many Houstonians with the announcement by Hearing Haven, LLC of ... hearing better on the job, and want to improve communications and ...
(Date:12/16/2009)... Ltd. is proud to announce being presented with the Weatherhead 100 ... the fastest growing companies in Northeast Ohio and is a testament ... , ... (PRWEB) December 16, 2009 -- ... the Weatherhead 100 Upstart Award on December 3, 2009. The ...
(Date:12/16/2009)... development of products that help survivors of stroke and other ... publication of an interview with the inventors of their brand ... Therapy and Rehab Medicine, vol. 20, issue 20, page 26, ... ... (PRWEB) December 16, 2009 -- In the publication, ...
(Date:12/16/2009)... will continue to offer free nationwide confidential legal consultations for ... effects such as: Birth Defects, Attempted Suicide, Suicide and Addiction ... free at 1-800-856-6405 or go to the firm’s website at ... form. , ... (PRWEB) December 16, ...
(Date:12/16/2009)... carrying Dr. Shapio,s Help Hair Shake in all of the Florida Whole ... ... 2009 -- Dr. Larry Shapiro, hair transplant and hair loss ... be carrying the Help Hair Whey Protein Shake. Dr. Shapiro developed ... adjunct for weight loss programs, working out and muscle building., , , ...
Breaking Medicine News(10 mins):Health News:Monthly Subscription Hearing Aid Plan Announced for Houston 2Health News:Request A Test Receives Weatherhead 100 Upstart Award 2Health News:New Tailwind Device Improves Arm Function in Stroke Survivors with Paralysis 2Health News:Ennis & Ennis, P.A. Announces Nationwide Free Legal Consultations For Users of Paxil 2Health News:Ennis & Ennis, P.A. Announces Nationwide Free Legal Consultations For Users of Paxil 3Health News:Florida Whole Foods Stores to Carry Dr. Lawrence Shapiro's Help Hair Shake 2
... gay governor, James E. McGreevy appears to be knocking on ... in the news// for the right reasons. He has been ... ,Former Gov. James E. McGreevy, who was brought up as ... on Sunday at St. Bartholomew's Church in New York. He ...
... units in UK is an eye-opener to prevailing malfunctions which ... a sting operation conducted by BBC, some maternity units came ... ,Some of the maternity units were facing an acute shortage ... work. The midwife in charge at a hospital where the ...
... survival has improved over time. However, for recipients with ... in the issue of Liver Transplantation. ,HCV-induced ... transplantation in the U.S., however, previous studies have shown ... liver transplantation. The difference has become even more striking ...
... States the gays prefer to find out whether their partner’s ... use protection to prevent// catching the disease. The risky behavior ... virus, which is on the rise. ,In Britain, ... virus and they continue to have unprotected sex. The saliva ...
... contaminated feed is causing concern among the people. The consumption of ... FDA is quick to play down the fear saying that it ... to light after some 38 chicken farms in Indiana was investigated ... chicken for human consumption with the contaminated feed. Until the investigation ...
... and the good fats in Omega-3 fatty acids help new ... the issue// of the International Breastfeeding Journal. ... anywhere from 10 percent to 20 percent of postpartum women. ... high as 40 percent or 50 percent. Since depression has ...
Other Medicine News:Health News:United Kingdom: Maternity Units Exposed! Leaves Much to Be Desired 2Health News:HCV Patients Survival After Liver Transplantation is Not Improving 2Health News:Unprotected Sex Among the Gays on the Rise 2Health News:Tainted Pet Food a Health Risk for Human? 2Health News:Breastfeeding and Omega-3 Fatty Acids Help New Moms Fight Depression 2
(Date:12/15/2009)... Services, Inc. (NYSE: WST ) today announced ... the first-quarter 2010 cash dividend of $0.16 per share. ... to shareholders of record on January 20, 2010. ... global manufacturer of components and systems for injectable drug ... and disposable components used in syringe, IV and blood ...
(Date:12/15/2009)... Del., Dec. 15 The U.S. Food and ... (EMDAC) today voted 12 yes, 4 no, and 1 ... the observed risks to support the use of CRESTOR® ... Men greater than or equal to 50 years, ... Fasting LDL < 130 mg/dL; hsCRP greater than ...
(Date:12/15/2009)... SRI International, an independent nonprofit research and development ... 7,592,021 for a new bioadhesive drug delivery system ... human body,s mucous membranes. This needle-free option uses ... much longer release time compared to alternatives such ... an effective means to introduce drugs across the ...
Breaking Medicine Technology:Favorable Vote from FDA Advisory Committee on Benefit/Risk of CRESTOR(R) (rosuvastatin calcium) in JUPITER Study 2Favorable Vote from FDA Advisory Committee on Benefit/Risk of CRESTOR(R) (rosuvastatin calcium) in JUPITER Study 3Favorable Vote from FDA Advisory Committee on Benefit/Risk of CRESTOR(R) (rosuvastatin calcium) in JUPITER Study 4Favorable Vote from FDA Advisory Committee on Benefit/Risk of CRESTOR(R) (rosuvastatin calcium) in JUPITER Study 5SRI International Receives U.S. Patent for Needle-Free Transmucosal Drug Delivery System 2SRI International Receives U.S. Patent for Needle-Free Transmucosal Drug Delivery System 3SRI International Receives U.S. Patent for Needle-Free Transmucosal Drug Delivery System 4SRI International Receives U.S. Patent for Needle-Free Transmucosal Drug Delivery System 5Are intravenous treatments safe 3F New research raises doubts 55731 1Are intravenous treatments safe 3F New research raises doubts 55731 2Open source DNA 55727 1New developments in reproductive medicine 9741 1New developments in reproductive medicine 9741 2
... Biotechnologies,announced today the results of Phase I/II and ... sarcoma and osteosarcoma, as,presented by Dr. Sant P. ... held in London UK on November 13-15, 2008. ... period up to 9 months. Analysis of,safety and ...
... PHILADELPHIA, Nov. 20 GlaxoSmithKline (NYSE: GSK ... and Drug Administration (FDA) granted accelerated approval for ... patients with chronic immune (idiopathic) thrombocytopenic purpura (ITP) ... immunoglobulins or splenectomy. The approval is a significant ...
Other Medicine Technology:Rexin-G Controls Tumor Growth and Improves Survival in Chemotherapy-Resistant Soft Tissue Sarcoma and Osteosarcoma: Phase I/II & Confirmatory Phase II Studies 2FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 2FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 3FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 4FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 5FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 6FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 7FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 8
The Pan Retinal® 2.2 uniquely combines magnification nearly that of the 20D lens with a field of view approaching that of the 30D lens. Excellent for virtually every examination procedure, includ...
This excellent mid-power lens provides medium field and magnification, with an ideal diameter for grip andmanipulation in the orbital area....
... Macula Plus® 5.5 is ... of the optic nerve ... it with your binocular ... choroidal neovascular membranes, macular ...
The iQ200 Automated Urinalysis System (iQ System) is a user-friendly, bench top, fully automated system that performs complete urinalyses on unspun specimens; simply load, press START and walk away....
Medicine Products: